United States · Series A startup

Who invested in Ankasa Regenerative Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

HealthcareBiotech

Funding summaryUpdated 31 Oct 2026

$8.5Mraised across 1 round since 2015, from 1 source

Latest round
Series A, $8.5MJun 2015
Investors
3
See who backed them

The rounds

  1. Jun 2015
    Series A$8.5M

    From a historical funding recordSEC filing: $9.5M sold, first sale May 2015

Everyone who backed them

Avalon VenturesVC firm1round
HeraeusCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Ankasa Regenerative Therapeutics

Who invested in Ankasa Regenerative Therapeutics?

Ankasa Regenerative Therapeutics's investors include Correlation Ventures, Avalon Ventures and Heraeus.

How much has Ankasa Regenerative Therapeutics raised?

Ankasa Regenerative Therapeutics has raised $8.5M across 1 round since 2015.

When did Ankasa Regenerative Therapeutics last raise?

Ankasa Regenerative Therapeutics's most recent round was a Series A of $8.5M in Jun 2015.

What was Ankasa Regenerative Therapeutics's biggest round?

Its most recent round, $8.5M in Jun 2015, is also its largest on record.

Who backed Ankasa Regenerative Therapeutics first?

Ankasa Regenerative Therapeutics's first round on record, in Jun 2015, was backed by Correlation Ventures, Avalon Ventures and Heraeus.

What stage is Ankasa Regenerative Therapeutics at?

Ankasa Regenerative Therapeutics's latest named round is a Series A, in Jun 2015.

Where is Ankasa Regenerative Therapeutics based?

Ankasa Regenerative Therapeutics is based in the United States.

Companies like Ankasa Regenerative Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.